Recruiting

Fecobionics

Sponsor:

The California Medical Innovations Institute, Inc.

Code:

NCT05412069

Conditions

Normal Subjects

Fecal Incontinence

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Fecobionics

Study Details

Brief summary:

The objective is to determine the length-tension properties of the anal sphincters using Fecobionics in normal subjects and FI patients during anal distension and during simulated evacuation. Fecobionics has the consistency and shape of normal stool and can record pressures, cross-sectional area, orientation and viscoelastic properties of the anorectum and can map the geometric profiles during evacuation, and thereby provides multi-dimensional measurements of pressures, deformability, and topographic changes. Fecobionics combines several existing tests to provide novel insight into anorectal function. The purpose for the development was to overcome the technological controversies and disagreement between various tests and unphysiological test conditions. The aim was to imitate defecation as much as possible to the natural process. Fecobionics was developed to simulate stool and to provide the driving pressure and resulting deformations of stool along with a measure of an objective anorectal angle during defecation in a single examination. Fecobionics makes it possible to describe objectively, without disturbing the defecation process, the opening characteristics and pressure signatures during initial entry into the relaxing anal canal.

The overall goal is to provide mechanistic understanding of defecation in health and defecatory disorders. It exceeds previous attempts to make artificial stool for evaluation of defecation (BET and FECOM) and integrates other technologies as well. It was designed to have a consistency and deformability of Type 4 (range type 3-5) on the Bristol stool form scale. The range from types 3-5 is found in 70% of normal subjects. A major novelty is that Fecobionics measures pressures in axial direction; i.e., in the flow direction.

Conditions

Normal Subjects

Fecal Incontinence

Study ID

NCT05412069

Start date

Feb 15, 2023

Status verified date

Oct, 2025

Completion date

Mar 31, 2027

Anticipated

Primary completion date

Dec 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Subject must provide written informed consent;
2. Willing and able to undergo required study tests, surveys, and procedures;
3. Age > 18 years of age.

Exclusion Criteria:

1. Female who is pregnant;
2. Prior anorectal surgery;
3. Prior bowel resection;
4. History of chronic constipation;
5. In the opinion of the investigator, the subject is not a suitable candidate for the study.

Study Design

Enrollment

155 participants

Anticipated

Allocation

Randomized

Intervention Model

Single group

Primary purpose

Basic Science

Interventions and Outcome Measures

Arms

experimental: Fecobionics study

Fecobionics

active comparator: Feco BFT

In this ARM Fecobionics will be used as a BFT tool

Interventions

Fecobionics

Fecobionics is a novel device to be inserted through the anal canal into rectum for studying defecation. Anorectal manometry, balloon expulsion test, and anal ultrasonography will be used as reference.

Primary outcome measure

  • Length-tension properties of the anal sphincter will be reported [ Time Frame: 1.5 year ]
  • Front-rear pressure difference (in cmH2O) will be measured [ Time Frame: 1.5 year ]

Central Contacts and Locations

Central contacts

Hans Gregersen, MD, PhD

8582497400hag@giome.org

Satish Rao, MD, PhD

7067212238srao@augusta.edu

Locations

Augusta University Medical Center

Recruiting

Augusta, Georgia, United States, 30912

Contacts

Satish Rao, MD, PhD

7067212238srao@augusta.edu

Tennekoon Karunaratne, MD, PhD

7067211968tkarunaratne@augusta.edu

More Information

Sponsor

The California Medical Innovations Institute, Inc.

Last update posted

Oct 21, 2025

Last verified

Oct, 2025

Keywords

  • anorectal
  • Fecobionics
  • defecation

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The California Medical Innovations Institute, Inc. on 2025-10-21.